Reflect Scientific, Inc. (RSCF)
USD 0.04
(-3.37%)
USD 0.04
(-3.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.66 Million USD | 9.1% |
| 2022 | 2.44 Million USD | -1.32% |
| 2021 | 2.47 Million USD | 47.87% |
| 2020 | 1.67 Million USD | 55.4% |
| 2019 | 1.07 Million USD | 82.02% |
| 2018 | 592.67 Thousand USD | 2.21% |
| 2017 | 579.84 Thousand USD | -8.04% |
| 2016 | 630.55 Thousand USD | -10.73% |
| 2015 | 706.37 Thousand USD | -16.25% |
| 2014 | 843.42 Thousand USD | -1.67% |
| 2013 | 857.74 Thousand USD | -35.15% |
| 2012 | 1.32 Million USD | -67.93% |
| 2011 | 4.12 Million USD | -9.3% |
| 2010 | 4.54 Million USD | -26.1% |
| 2009 | 6.15 Million USD | -33.37% |
| 2008 | 9.23 Million USD | -5.94% |
| 2007 | 9.81 Million USD | 41.8% |
| 2006 | 6.92 Million USD | 504.34% |
| 2005 | 1.14 Million USD | 74.14% |
| 2004 | 657.92 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.67 Million USD | 0.29% |
| 2024 Q2 | 2.32 Million USD | -13.08% |
| 2023 FY | 2.66 Million USD | 9.1% |
| 2023 Q4 | 2.66 Million USD | -1.38% |
| 2023 Q3 | 2.7 Million USD | 8.66% |
| 2023 Q1 | 2.26 Million USD | -7.33% |
| 2023 Q2 | 2.49 Million USD | 9.87% |
| 2022 Q3 | 2.49 Million USD | -10.73% |
| 2022 Q1 | 2.67 Million USD | 7.78% |
| 2022 Q4 | 2.44 Million USD | -1.82% |
| 2022 FY | 2.44 Million USD | -1.32% |
| 2022 Q2 | 2.79 Million USD | 4.46% |
| 2021 Q2 | 2.03 Million USD | 5.4% |
| 2021 Q1 | 1.93 Million USD | 15.36% |
| 2021 FY | 2.47 Million USD | 47.87% |
| 2021 Q4 | 2.47 Million USD | 18.81% |
| 2021 Q3 | 2.08 Million USD | 2.36% |
| 2020 FY | 1.67 Million USD | 55.4% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 1.67 Million USD | 0.0% |
| 2019 Q4 | 1.07 Million USD | 32.69% |
| 2019 FY | 1.07 Million USD | 82.02% |
| 2019 Q3 | 813.03 Thousand USD | 28.72% |
| 2019 Q2 | 631.63 Thousand USD | -9.62% |
| 2019 Q1 | 698.82 Thousand USD | 17.91% |
| 2018 Q3 | 598.5 Thousand USD | 3.41% |
| 2018 Q4 | 592.67 Thousand USD | -0.97% |
| 2018 FY | 592.67 Thousand USD | 2.21% |
| 2018 Q1 | 610.01 Thousand USD | 5.2% |
| 2018 Q2 | 578.76 Thousand USD | -5.12% |
| 2017 FY | 579.84 Thousand USD | -8.04% |
| 2017 Q2 | 614.41 Thousand USD | 3.51% |
| 2017 Q1 | 593.57 Thousand USD | -5.86% |
| 2017 Q4 | 579.84 Thousand USD | -14.62% |
| 2017 Q3 | 679.16 Thousand USD | 10.54% |
| 2016 FY | 630.55 Thousand USD | -10.73% |
| 2016 Q4 | 630.55 Thousand USD | -5.81% |
| 2016 Q2 | 725.91 Thousand USD | 10.2% |
| 2016 Q1 | 658.73 Thousand USD | -6.74% |
| 2016 Q3 | 669.46 Thousand USD | -7.78% |
| 2015 Q4 | 706.37 Thousand USD | -8.5% |
| 2015 FY | 706.37 Thousand USD | -16.25% |
| 2015 Q3 | 772.02 Thousand USD | 6.07% |
| 2015 Q2 | 727.85 Thousand USD | -8.54% |
| 2015 Q1 | 795.83 Thousand USD | -5.64% |
| 2014 Q4 | 843.42 Thousand USD | -2.4% |
| 2014 Q3 | 864.13 Thousand USD | -7.54% |
| 2014 FY | 843.42 Thousand USD | -1.67% |
| 2014 Q2 | 934.6 Thousand USD | 1.78% |
| 2014 Q1 | 918.28 Thousand USD | 7.06% |
| 2013 FY | 857.74 Thousand USD | -35.15% |
| 2013 Q4 | 857.74 Thousand USD | -23.82% |
| 2013 Q3 | 1.12 Million USD | -1.43% |
| 2013 Q2 | 1.14 Million USD | -3.25% |
| 2013 Q1 | 1.18 Million USD | -10.74% |
| 2012 FY | 1.32 Million USD | -67.93% |
| 2012 Q2 | 3.89 Million USD | -2.21% |
| 2012 Q1 | 3.97 Million USD | -3.52% |
| 2012 Q3 | 3.77 Million USD | -2.92% |
| 2012 Q4 | 1.32 Million USD | -64.99% |
| 2011 Q1 | 4.5 Million USD | -0.93% |
| 2011 Q3 | 4.37 Million USD | -1.26% |
| 2011 Q2 | 4.42 Million USD | -1.69% |
| 2011 FY | 4.12 Million USD | -9.3% |
| 2011 Q4 | 4.12 Million USD | -5.68% |
| 2010 Q1 | 4.65 Million USD | -24.32% |
| 2010 Q4 | 4.54 Million USD | -3.83% |
| 2010 FY | 4.54 Million USD | -26.1% |
| 2010 Q3 | 4.72 Million USD | 2.27% |
| 2010 Q2 | 4.62 Million USD | -0.71% |
| 2009 Q3 | 7.3 Million USD | -9.81% |
| 2009 Q2 | 8.1 Million USD | -7.1% |
| 2009 Q1 | 8.71 Million USD | -5.58% |
| 2009 FY | 6.15 Million USD | -33.37% |
| 2009 Q4 | 6.15 Million USD | -15.77% |
| 2008 FY | 9.23 Million USD | -5.94% |
| 2008 Q3 | 10.03 Million USD | -1.16% |
| 2008 Q2 | 10.15 Million USD | 1.58% |
| 2008 Q1 | 9.99 Million USD | 1.81% |
| 2008 Q4 | 9.23 Million USD | -7.98% |
| 2007 Q2 | 12.21 Million USD | 20.94% |
| 2007 Q4 | 9.81 Million USD | -6.01% |
| 2007 FY | 9.81 Million USD | 41.8% |
| 2007 Q3 | 10.44 Million USD | -14.48% |
| 2007 Q1 | 10.1 Million USD | 45.88% |
| 2006 Q2 | 6.86 Million USD | 362.84% |
| 2006 Q3 | 6.6 Million USD | -3.74% |
| 2006 Q4 | 6.92 Million USD | 4.8% |
| 2006 Q1 | 1.48 Million USD | 29.42% |
| 2006 FY | 6.92 Million USD | 504.34% |
| 2005 FY | 1.14 Million USD | 74.14% |
| 2005 Q3 | 1.18 Million USD | -13.87% |
| 2005 Q1 | 1.08 Million USD | 0.0% |
| 2005 Q4 | 1.14 Million USD | -3.14% |
| 2005 Q2 | 1.37 Million USD | 26.92% |
| 2004 FY | 657.92 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -45.202% |
| Ansell Limited | 3.23 Billion USD | 99.918% |
| Ansell Limited | 3.24 Billion USD | 99.918% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.454% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -788.562% |
| Psykey, Inc. | 1.72 Million USD | -54.508% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.928% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.928% |
| Encision Inc. | 3.81 Million USD | 29.963% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -309.416% |
| LifePoint, Inc. | 8.8 Million USD | 69.703% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 83.273% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -198.201% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 51.378% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.553% |
| Sector 10, Inc. | 1000.00 USD | -266790.3% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.944% |
| SheerVision, Inc. | 837.56 Thousand USD | -218.65% |
| United Health Products, Inc. | 284.64 Thousand USD | -837.632% |
| Vasamed, Inc. | 1.6 Million USD | -66.781% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1095.89% |
| Yubo International Biotech Limited | 2.34 Million USD | -13.64% |